Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Gastrointestinal 2

Conditions

Breast Neoplasms 68Prostatic Neoplasms 44Leukemia, Myeloid, Acute 35Melanoma 34Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 28Pancreatic Neoplasms 26Myelodysplastic Syndromes 23Multiple Myeloma 23Colorectal Neoplasms 23Leukemia, Lymphocytic, Chronic, B-Cell 22Neoplasms 21Squamous Cell Carcinoma of Head and Neck 19Neoplasm Metastasis 19Lymphoma, Large B-Cell, Diffuse 19Rectal Neoplasms 16Lymphoma, Mantle-Cell 14Carcinoma, Renal Cell 14Triple Negative Breast Neoplasms 13Stomach Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colonic Neoplasms 13Lymphoma, Follicular 12Uterine Cervical Neoplasms 11Ovarian Neoplasms 11Leukemia, Myelomonocytic, Chronic 11Head and Neck Neoplasms 11Esophageal Neoplasms 11Myeloproliferative Disorders 10Mouth Neoplasms 9

Interventions

Imatinib Mesylate 32regorafenib 9Sunitinib 9Laparoscopy 5Dasatinib 4Blood Specimen Collection 4pazopanib 3nilotinib 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Paclitaxel 3Observation 3spartalizumab 2ripretinib 2envafolimab 2binimetinib 2apatinib 2Temozolomide 2Neoadjuvant Therapy 2Ipilimumab 2Gemcitabine 2Docetaxel 2Cisplatin 2Carboplatin 2Capecitabine 2CTLA-4 Antigen 2Biopsy, Fine-Needle 2Biopsy 25-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Gastrointestinal Stromal Tumors × Biopsy × Clear all
NCT01991379 2025-12-04

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Memorial Sloan Kettering Cancer Center

Phase 1/2 Active not recruiting
75 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT02931981 2016-10-13

Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor

RenJi Hospital

Unknown
50 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡